NASDAQ: CALC
CalciMedica, Inc.
Healthcare · Biotechnology
After hours: $0.70(+1.21%) · as of 7:51 PM ET
Market Cap
$10.82M
52w High
$7.20
52w Low
$0.46
P/E
-0.52
Volume
378.16K
Outstanding Shares
15.74M
Price vs Fundamentals
Why The Stock Is Moving
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
What changed
The stock fell 76.37% over the last year. Free cash flow grew 0.71% over the trailing twelve months.
What the market seems to be pricing
The stock has moved lower with no clear directional signal from operating metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
A decisive shift in revenue or cash flow over the next period would be the clearest signal to resolve the ambiguity.
Company profile
CalciMedica, Inc., a clinical-stage biotechnology company headquartered in La Jolla, California, is focused on creating treatments for life-threatening inflammatory diseases that currently lack adequate therapies.
Valuation
Stock splits
Every 14 shares became 1
Profitability & growth
Analyst consensus
2
Buy
1
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Aug 11, 2026
Q3 FY26 · EPS est -$0.33 · Revenue est —
View